×
About 8,013 results

ALLMedicine™ Urticaria Center

Research & Reviews  1,926 results

New markers to predict the response to omalizumab in chronic spontaneous urticaria.
https://doi.org/10.1111/dth.15589
Dermatologic Therapy; Coşansu NC, Kara RÖ et. al.

May 19th, 2022 - Omalizumab has high treatment efficacy in patients with chronic spontaneous urticaria (CSU) who do not respond to high doses of antihistamines. Systemic immune-inflammation index (SII) and systemic inflammation response index (SIRI) were described...

Is benzophenone safe in skin care? Part 1: Risks to humans
https://www.mdedge.com/dermatology/article/254723/aesthetic-dermatology/benzophenone-safe-skin-care-part-1-risks-humans
Leslie S. Baumann, MD

May 18th, 2022 - Benzophenones are a family of compounds that include dixoxybenzone, sulisobenzone, and benzophenone-3, or oxybenzone. These benzophenones are found in various skin care and personal care products, including body washes, exfoliants, fragrances, liq.

Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic Mastocytosis
https://clinicaltrials.gov/ct2/show/NCT03770273

May 13th, 2022 - Systemic mastocytosis is a disorder caused by clonal mast cell proliferation and release of mast cell mediators including tryptase. As a result, mast cell numbers may increase and affect target organs including the dermis (maculopapular cutaneous ...

Cholinergic Urticaria - Efficacy of Dupilumab
https://clinicaltrials.gov/ct2/show/NCT03749148

May 13th, 2022 - Treatment with Dupilumab has been shown to reduce clinically significant exacerbations and to improve skin symptom control as well as quality of life in moderate to severe atopic dermatitis patients and in moderate to severe asthma patients. It ha...

A Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Efficacy of UB-221 IV Infusion as an add-on Therapy in Patients With Chronic Spontaneous Urticaria
https://clinicaltrials.gov/ct2/show/NCT05298215

May 13th, 2022 - This is a phase II, double-blind, randomized, parallel group, placebo-controlled study to evaluate the pharmacodynamics, pharmacokinetics, efficacy, and safety of 2-dose UB-221 IV infusion as an add-on therapy in patients with chronic spontaneous ...

see more →

Guidelines  6 results

Considerations on biologicals for patients with allergic disease in times of the COVID-...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300800
Allergy Vultaggio A, Agache I et. al.

Jun 6th, 2020 - The outbreak of the SARS-CoV-2-induced coronavirus disease 2019 (COVID-19) pandemic re-shaped doctor-patient interaction and challenged capacities of healthcare systems. It created many issues around the optimal and safest way to treat complex pat...

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and ma...
https://doi.org/10.1111/all.13397
Allergy Zuberbier T, Aberer W et. al.

Jan 18th, 2018 - This evidence- and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. The conference was held on 1 December 2016. I...

Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/...
https://doi.org/10.1111/all.12370
Allergy Zuberbier T, Aberer W et. al.

Jun 6th, 2014 - This methods report describes the process of guideline development in detail. It is the result of a systematic literature review using the 'Grading of Recommendations Assessment, Development and Evaluation' (GRADE) methodology and a structured con...

Sclerotherapy of varicose veins with polidocanol based on the guidelines of the German ...
https://doi.org/10.1111/j.1524-4725.2010.01495.x
Dermatologic Surgery : Official Publication for American ... Rabe E, Pannier F

Jul 16th, 2010 - Sclerotherapy involves the injection of a sclerosing agent for the elimination of intracutaneous, subcutaneous, and transfascial varicose veins. To update guidelines for sclerotherapy of varicose veins. The guidelines for sclerotherapy of varicose...

EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria.
https://doi.org/10.1111/j.1398-9995.2009.02179.x
Allergy Zuberbier T, Asero R et. al.

Sep 24th, 2009 - This guideline, together with its sister guideline on the management of urticaria [Zuberbier T, Asero R, Bindslev-Jensen C, Canonica GW, Church MK, Giménez-Arnau AM et al. EAACI/GA(2)LEN/EDF/WAO Guideline: Management of urticaria. Allergy, 2009; 6...

see more →

Drugs  912 results see all →

Clinicaltrials.gov  73 results

Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic Mastocytosis
https://clinicaltrials.gov/ct2/show/NCT03770273

May 13th, 2022 - Systemic mastocytosis is a disorder caused by clonal mast cell proliferation and release of mast cell mediators including tryptase. As a result, mast cell numbers may increase and affect target organs including the dermis (maculopapular cutaneous ...

Cholinergic Urticaria - Efficacy of Dupilumab
https://clinicaltrials.gov/ct2/show/NCT03749148

May 13th, 2022 - Treatment with Dupilumab has been shown to reduce clinically significant exacerbations and to improve skin symptom control as well as quality of life in moderate to severe atopic dermatitis patients and in moderate to severe asthma patients. It ha...

Safety and Efficacy of TLL018 in Patients With Chronic Spontaneous Urticaria.
https://clinicaltrials.gov/ct2/show/NCT05373355

May 13th, 2022 - Successfully screened subjects will be randomized in a ratio of 1:1:1. After a 4-week screening period (day -28-0), subjects will be randomly assigned to treatment for 12 weeks. Clinical Urticaria Activity Score (UAS), dermatological Quality of ...

A Study of MTPS9579A in Participants With Refractory Chronic Spontaneous Urticaria
https://clinicaltrials.gov/ct2/show/NCT05129423

May 13th, 2022 - This pilot and dose-ranging study will evaluate the efficacy, safety, and pharmacokinetics of MTPS9579A compared with placebo in participants with chronic spontaneous urticaria (CSU) refractory to antihistamines. This study comprises two parts. In...

A Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Efficacy of UB-221 IV Infusion as an add-on Therapy in Patients With Chronic Spontaneous Urticaria
https://clinicaltrials.gov/ct2/show/NCT05298215

May 13th, 2022 - This is a phase II, double-blind, randomized, parallel group, placebo-controlled study to evaluate the pharmacodynamics, pharmacokinetics, efficacy, and safety of 2-dose UB-221 IV infusion as an add-on therapy in patients with chronic spontaneous ...

see more →

News  278 results

Is benzophenone safe in skin care? Part 1: Risks to humans
https://www.mdedge.com/dermatology/article/254723/aesthetic-dermatology/benzophenone-safe-skin-care-part-1-risks-humans
Leslie S. Baumann, MD

May 18th, 2022 - Benzophenones are a family of compounds that include dixoxybenzone, sulisobenzone, and benzophenone-3, or oxybenzone. These benzophenones are found in various skin care and personal care products, including body washes, exfoliants, fragrances, liq.

Activity Score Helps Cold Urticaria Patients Monitor Their Signs, Symptoms, and Encounters With Cold
https://www.medscape.com/viewarticle/973382

May 4th, 2022 - A newly developed rating scale called the Cold Urticaria Activity Score (ColdUAS) can help patients with cold urticaria (ColdU) monitor their signs, symptoms, exposure to cold, and avoidance of cold by answering four simple questions, according to...

A case of cold, purple toes
https://www.mdedge.com/familymedicine/article/253770/dermatology/case-cold-purple-toes
MDedge Family Medicine;

Apr 14th, 2022 - A punch-biopsy was performed on the left second toe where the erythema was the most intense. It demonstrated classic findings for pernio: superficial and deep perivascular lymphocytic inflammation and papillary dermal edema on the acral surface.

Treat or Refer? New Primary Care Flow Diagrams for Allergy Patients
https://www.medscape.com/viewarticle/971747

Apr 7th, 2022 - A recently published set of treatment flow diagrams uses simplified diagnosis and management pathways to help primary care providers (PCPs) in Europe, the United States, and elsewhere treat patients with allergies. Most patients with allergy probl...

Chronic Urticaria Clinical Practice Guidelines (BAD, 2021)
https://www.medscape.com/viewarticle/971251

Mar 31st, 2022 - Guidelines on the management of chronic urticaria were first published in November 2021 by the British Association of Dermatologists (BAD) in the British Journal of Dermatology.[1] Selected recommendations are outlined below. All Types of Chronic ...

see more →

Patient Education  10 results see all →